Patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly allocated (2:1) to 6 weeks oxaliplatin-fluoropyrimidine preoperatively plus 18 postoperatively (NAC group) or 24 weeks ...
Clinical trials are the quicksand of drug development. Clinical trials to support a new drug can drag out for six to seven years, on average, with a median cost of $19 million. Now, using machine ...
New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed this way. By Teddy Rosenbluth The Department of Health and Human Services ...
A study undertaken across the UK and Canada has found a wearable fitness tracker watch can be helpful in treatment of those who have been recently diagnosed with diabetes. The randomly controlled ...
Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma) Novel cancer drugs can produce higher and more ...
Closed-loop control systems of insulin delivery may improve glycemic outcomes in young children with type 1 diabetes. The efficacy and safety of initiating a closed-loop system virtually are unclear.
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Este artículo estará disponible en español en El Tiempo Latino. Health and Human Services Secretary Robert F. Kennedy Jr. has a long history of undermining confidence in vaccine safety, including by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback